(Q46970782)

English

Pre-treatment with 3,4-methylenedioxymethamphetamine (MDMA) causes long-lasting changes in 5-HT2A receptor-mediated glucose utilization in the rat brain

scientific article published in March 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

27 December 2017

http://europepmc.org/abstract/MED/16510485

0 references

Pre-treatment with 3,4-methylenedioxymethamphetamine (MDMA) causes long-lasting changes in 5-HT2A receptor-mediated glucose utilization in the rat brain (English)

1 reference

Europe PubMed Central

27 December 2017

http://europepmc.org/abstract/MED/16510485

author name string

Eleanor J Bull

1

1 reference

Europe PubMed Central

27 December 2017

http://europepmc.org/abstract/MED/16510485

Veronica Porkess

2

1 reference

Europe PubMed Central

27 December 2017

http://europepmc.org/abstract/MED/16510485

Michael Rigby

3

1 reference

Europe PubMed Central

27 December 2017

http://europepmc.org/abstract/MED/16510485

Peter H Hutson

4

1 reference

Europe PubMed Central

27 December 2017

http://europepmc.org/abstract/MED/16510485

Kevin C F Fone

5

1 reference

Europe PubMed Central

27 December 2017

http://europepmc.org/abstract/MED/16510485

language of work or name

0 references

publication date

1 March 2006

1 reference

Europe PubMed Central

27 December 2017

http://europepmc.org/abstract/MED/16510485

Journal of Psychopharmacology

1 reference

Europe PubMed Central

27 December 2017

http://europepmc.org/abstract/MED/16510485

20

1 reference

Europe PubMed Central

27 December 2017

http://europepmc.org/abstract/MED/16510485

2

1 reference

Europe PubMed Central

27 December 2017

http://europepmc.org/abstract/MED/16510485

272-280

1 reference

Europe PubMed Central

27 December 2017

http://europepmc.org/abstract/MED/16510485

Striatal dopamine release in vivo following neurotoxic doses of methamphetamine and effect of the neuroprotective drugs, chlormethiazole and dizocilpine

1 reference

https://api.crossref.org/works/10.1177%2F0269881106059583

21 January 2018

Long-term effects of 'ecstasy' abuse on the human brain studied by FDG PET.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106059583

21 January 2018

Reduced social interaction following 3,4-methylenedioxymethamphetamine is not associated with enhanced 5-HT 2C receptor responsivity

1 reference

https://api.crossref.org/works/10.1177%2F0269881106059583

21 January 2018

Decreased social behaviour following 3,4-methylenedioxymethamphetamine (MDMA) is accompanied by changes in 5-HT2A receptor responsivity

1 reference

https://api.crossref.org/works/10.1177%2F0269881106059583

21 January 2018

Persistent loss of thermoregulation in the rat induced by 3,4-methylenedioxymethamphetamine (MDMA or "Ecstasy") but not by fenfluramine.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106059583

21 January 2018

Pre-exposure to (+/-)3,4-methylenedioxy-methamphetamine (MDMA) facilitates acquisition of intravenous cocaine self-administration in rats

1 reference

https://api.crossref.org/works/10.1177%2F0269881106059583

21 January 2018

Long-term changes in social interaction and reward following repeated MDMA administration to adolescent rats without accompanying serotonergic neurotoxicity

1 reference

https://api.crossref.org/works/10.1177%2F0269881106059583

21 January 2018

Increased CRE-binding activity and tryptophan hydroxylase mRNA expression induced by 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") in the rat frontal cortex but not in the hippocampus

1 reference

https://api.crossref.org/works/10.1177%2F0269881106059583

21 January 2018

A role for the mesolimbic dopamine system in the psychostimulant actions of MDMA.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106059583

21 January 2018

A review of the mechanisms involved in the acute MDMA (ecstasy)-induced hyperthermic response

1 reference

https://api.crossref.org/works/10.1177%2F0269881106059583

21 January 2018

Increased anxiety in rats after 3,4-methylenedioxymethamphetamine: association with serotonin depletion

1 reference

https://api.crossref.org/works/10.1177%2F0269881106059583

21 January 2018

Neural mechanisms of drug reinforcement

1 reference

https://api.crossref.org/works/10.1177%2F0269881106059583

21 January 2018

Psychological and physiological effects of MDMA ("Ecstasy") after pretreatment with the 5-HT(2) antagonist ketanserin in healthy humans

1 reference

https://api.crossref.org/works/10.1177%2F0269881106059583

21 January 2018

Behavioural analysis of the acute and chronic effects of MDMA treatment in the rat.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106059583

21 January 2018

Changes in serotonin, dopamine and noradrenaline levels in striatum and nucleus accumbens after repeated administration of the abused drug MDMA in rats

1 reference

https://api.crossref.org/works/10.1177%2F0269881106059583

21 January 2018

A neurotoxic dose of 3,4-methylenedioxymethamphetamine (MDMA; ecstasy) to rats results in a long-term defect in thermoregulation

1 reference

https://api.crossref.org/works/10.1177%2F0269881106059583

21 January 2018

The pharmacology of the acute hyperthermic response that follows administration of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') to rats

1 reference

https://api.crossref.org/works/10.1177%2F0269881106059583

21 January 2018

Localization of the mRNA for the 5-HT2 receptor by in situ hybridization histochemistry. Correlation with the distribution of receptor sites

1 reference

https://api.crossref.org/works/10.1177%2F0269881106059583

21 January 2018

Serotonin neurons of the midbrain raphe: ascending projections

1 reference

https://api.crossref.org/works/10.1177%2F0269881106059583

21 January 2018

Repeated administration of 3,4-methylenedioxymethamphetamine augments cocaine's action on dopamine in the nucleus accumbens: a microdialysis study.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106059583

21 January 2018

Increased anxiety and impaired memory in rats 3 months after administration of 3,4-methylenedioxymethamphetamine ("ecstasy").

1 reference

https://api.crossref.org/works/10.1177%2F0269881106059583

21 January 2018

Methylenedioxymethamphetamine-induced inhibition of neuronal firing in the nucleus accumbens is mediated by both serotonin and dopamine.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106059583

21 January 2018

Specific neurotoxicity of chronic use of ecstasy

1 reference

https://api.crossref.org/works/10.1177%2F0269881106059583

21 January 2018

Quantitative autoradiographic mapping of serotonin receptors in the rat brain. II. Serotonin-2 receptors.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106059583

21 January 2018

Distribution of the serotonin 5-HT2 receptor family mRNAs: comparison between 5-HT2A and 5-HT2C receptors.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106059583

21 January 2018

Functional consequences of acute cocaine treatment depend on route of administration.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106059583

21 January 2018

Selective alterations in cerebral metabolism within the mesocorticolimbic dopaminergic system produced by acute cocaine administration in rats.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106059583

21 January 2018

Correlation of dose-dependent effects of acute amphetamine administration on behavior and local cerebral metabolism in rats.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106059583

21 January 2018

Acute methylenedioxymethamphetamine administration: effects on local cerebral blood flow and glucose utilisation in the Dark Agouti rat.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106059583

21 January 2018

The acute and chronic effects of MDMA ("ecstasy") on cortical 5-HT2A receptors in rat and human brain

1 reference

https://api.crossref.org/works/10.1177%2F0269881106059583

21 January 2018

Hallucinogenic drug interactions at human brain 5-HT2 receptors: implications for treating LSD-induced hallucinogenesis

1 reference

https://api.crossref.org/works/10.1177%2F0269881106059583

21 January 2018

Neurotoxicity of MDMA: neurochemical effects

1 reference

https://api.crossref.org/works/10.1177%2F0269881106059583

21 January 2018

Influence of plasma glucose concentration on lumped constant of the deoxyglucose method: effects of hyperglycemia in the rat.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106059583

21 January 2018

Alterations in hippocampal function following repeated exposure to the amphetamine derivative methylenedioxymethamphetamine ("Ecstasy").

1 reference

https://api.crossref.org/works/10.1177%2F0269881106059583

21 January 2018

The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106059583

21 January 2018

The effects of 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxyamphetamine (MDA) on monoaminergic systems in the rat brain.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106059583

21 January 2018

Synaptic plasticity in the mesolimbic dopamine system

1 reference

https://api.crossref.org/works/10.1177%2F0269881106059583

21 January 2018

Radioligand binding evidence implicates the brain 5-HT2 receptor as a site of action for LSD and phenylisopropylamine hallucinogens

1 reference

https://api.crossref.org/works/10.1177%2F0269881106059583

21 January 2018

Effects of methylenedioxymethamphetamine on local cerebral glucose utilization in the rat.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106059583

21 January 2018

The acute effects of methylenedioxymethamphetamine on dopamine release in the awake-behaving rat.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106059583

21 January 2018

Enhanced accumbal dopamine release following 5-HT(2A) receptor stimulation in rats pretreated with intermittent cocaine

1 reference

https://api.crossref.org/works/10.1177%2F0269881106059583

21 January 2018

Identifiers

10.1177/0269881106059583

1 reference

Europe PubMed Central

27 December 2017

http://europepmc.org/abstract/MED/16510485

1 reference

Europe PubMed Central

27 December 2017

http://europepmc.org/abstract/MED/16510485

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46970782&oldid=2140189496"